Annual Cash & Cash Equivalents
$8.56 M
-$8.87 M-50.87%
31 December 2023
Summary:
TRACON Pharmaceuticals annual cash & cash equivalents is currently $8.56 million, with the most recent change of -$8.87 million (-50.87%) on 31 December 2023. During the last 3 years, it has fallen by -$23.57 million (-73.35%). TCON annual cash & cash equivalents is now -79.30% below its all-time high of $41.37 million, reached on 31 December 2015.TCON Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$6.27 M
-$1.62 M-20.54%
30 June 2024
Summary:
TRACON Pharmaceuticals quarterly cash and cash equivalents is currently $6.27 million, with the most recent change of -$1.62 million (-20.54%) on 30 June 2024. Over the past year, it has dropped by -$1.49 million (-19.23%). TCON quarterly cash and cash equivalents is now -90.40% below its all-time high of $65.29 million, reached on 31 March 2015.TCON Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCON Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.9% | -19.2% |
| 3 y3 years | -73.3% | -79.0% |
| 5 y5 years | -65.9% | -67.1% |
TCON Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.3% | at low | -79.0% | +261.4% |
| 5 y | 5 years | -73.3% | at low | -80.5% | +261.4% |
| alltime | all time | -79.3% | +276.3% | -90.4% | +261.4% |
TRACON Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $6.27 M(-20.5%) |
| Mar 2024 | - | $7.89 M(-7.9%) |
| Dec 2023 | $8.56 M(-50.9%) | $8.56 M(+10.3%) |
| Sept 2023 | - | $7.76 M(+347.4%) |
| June 2023 | - | $1.74 M(-73.8%) |
| Mar 2023 | - | $6.61 M(-62.1%) |
| Dec 2022 | $17.43 M(-27.6%) | $17.43 M(+2.3%) |
| Sept 2022 | - | $17.04 M(+25.5%) |
| June 2022 | - | $13.58 M(-18.4%) |
| Mar 2022 | - | $16.64 M(-30.9%) |
| Dec 2021 | $24.07 M(-25.1%) | $24.07 M(-19.5%) |
| Sept 2021 | - | $29.90 M(+16.9%) |
| June 2021 | - | $25.58 M(-3.1%) |
| Mar 2021 | - | $26.41 M(-17.8%) |
| Dec 2020 | $32.13 M(+95.8%) | $32.13 M(+21.5%) |
| Sept 2020 | - | $26.45 M(+83.0%) |
| June 2020 | - | $14.45 M(+2.3%) |
| Mar 2020 | - | $14.13 M(-13.9%) |
| Dec 2019 | $16.41 M | $16.41 M(-13.9%) |
| Sept 2019 | - | $19.05 M(-27.7%) |
| June 2019 | - | $26.34 M(+19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $22.09 M(-12.1%) |
| Dec 2018 | $25.14 M(-14.7%) | $25.14 M(-10.8%) |
| Sept 2018 | - | $28.19 M(-18.1%) |
| June 2018 | - | $34.43 M(-44.9%) |
| Mar 2018 | - | $62.49 M(+112.1%) |
| Dec 2017 | $29.47 M(-17.5%) | $29.47 M(-10.3%) |
| Sept 2017 | - | $32.86 M(+26.4%) |
| June 2017 | - | $26.00 M(-19.3%) |
| Mar 2017 | - | $32.22 M(-9.8%) |
| Dec 2016 | $35.71 M(-13.7%) | $35.71 M(+20.4%) |
| Sept 2016 | - | $29.65 M(-12.9%) |
| June 2016 | - | $34.02 M(-21.4%) |
| Mar 2016 | - | $43.27 M(+4.6%) |
| Dec 2015 | $41.37 M(+18.2%) | $41.37 M(-12.3%) |
| Sept 2015 | - | $47.15 M(-22.9%) |
| June 2015 | - | $61.16 M(-6.3%) |
| Mar 2015 | - | $65.29 M(+86.5%) |
| Dec 2014 | $35.00 M(+1437.8%) | $35.00 M(-10.7%) |
| Sept 2014 | - | $39.21 M(+1622.6%) |
| Dec 2013 | $2.28 M(-7.4%) | $2.28 M |
| Dec 2012 | $2.46 M | - |
FAQ
- What is TRACON Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is TRACON Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is TRACON Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of TCON is $8.56 M
What is the all time high annual cash & cash equivalents for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high annual cash & cash equivalents is $41.37 M
What is TRACON Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, TCON annual cash & cash equivalents has changed by -$8.87 M (-50.87%)
What is TRACON Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TCON is $6.27 M
What is the all time high quarterly cash and cash equivalents for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high quarterly cash and cash equivalents is $65.29 M
What is TRACON Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, TCON quarterly cash and cash equivalents has changed by -$1.49 M (-19.23%)